compounded glp 1 lawsuit Prescription by Algorithm: The Ethical and Legal Questions Behind GLP-1 Advertising Troubling Findings in Study of

Pharmaceutical giants have been critical of PBMs, saying their role needs to change

Liraglutide has anti-inflammatory and anti-amyloid properties in streptozotocin-induced and 5xFAD mouse models of alzheimers disease

Blossom Inuenwi, DNP, focuses on creating customized weight loss plans that align with each patients unique journey

Pathogenesis and Negative Impact of Diabetes Mellitus in Liver Transplant Recipients The global increase in diabetes mellitus has led to a substantial rise in its prevalence among liver transplant candidates

A medicine supply notification issued by the Department of Health and Social Care on 27 June 2023 said the high impact shortage has been caused by an increase in demand for these products for licensed and off-label indications, with supply not expected to return to normal until at least mid-2024

Big picture view: The lawsuit highlights ongoing issues with access and affordability as GLP-1 drugs become more popular